Zempilo, Amalungiselelo
Drug "Glucosamine + Chondroitin." Inkcazelo. Iimpawu ze isicelo
Amalungiselelo kunye glucosamine kunye chondroitin uncedo ukubuyisela intlala nokomeleza kwizicwili. Luthetha ukuba imveliso ulwelo lwamalunga, ukunciphisa ukukhathala kwezihlunu.
additive Ukutya "Glucosamine + Chondroitin." indlela isenzo
Glucosamine ifumaneka kweendonga semithambo, ulusu, bronchi, yangaphakathi. molecule lwayo kugaywe kwisiqwenga zesisu, apho kufikwa intlala nezinye kwizihlunu. Kukho ubethwa nokulungelelanisa glucosamine ukuvelisa amacandelo kuyimfuneko, kuquka chondroitin sulfate. Last abangaphangeliyo umsebenzi enqanda proteolytic ukuba negalelo intlala intshabalalo, ngandlela anti-ezithintela ukosuleleka kunye iintlungu, kunciphisa intlungu umnqonqo kunye namalungu ukuba aphumle kwaye ihamba.
iipropati ngxenye
Iibhloko zokwakha ezingundoqo kukwenziwa kwizicwili yi glucosamine. Eli candelo ithatha inxaxheba ukuyilwa imisipha, nemisipha, intlala, amalungu. Xa reception rhoqo glucosamine ukucola phantsi ukuphuhliswa kweenkqubo zophendlo lwezifo kwamalunga, izicwili ezithambileyo kunye umqolo sisiba mandundu. Chondroitin sulfate inikeza ushukumisa hyaluronic acid yokuqaphela. Candelo komeleza isakhiwo kwizicwili. Unxulumene arhente udidi chondroprotective, ukwandisa okutsha nokunyusa iimpawu ukunceda le intlala.
Ubungqina obubonakalayo buxela
Lithetha "Glucosamine + Chondroitin" (a ekhemesti ngokumiselwa) kucetyiswa xa ezimbi yomqolo kunye namalungu nohlobo sisiba mandundu. Ingakumbi, bayibiza ukufundwa of arthropathy, osteoarthritis, osteochondrosis (intervertebral) spondylosis.
umthamo abakwisigaba
Ichiza inikwa izigulane kunye iminyaka elishumi elinesihlanu. Kucetyiswa ukuba ezi njengezingxobo imizuzu engamashumi amathathu ukuya amane phambi kokuba batye. Ithamo ekucetyiswa lithetha "Glucosamine + Chondroitin" - kabini ngosuku 1 pc. ngexesha kwiiveki ezintathu zokuqala. Kamva, amaza ulwamkelo kuncitshiswa ngesiqingatha - capsule kuba kanye ngemini.
imiphumela emibi
Practice ubonisa ukuba imiphumela emibi kuvela xa kunene pamo acetyiswayo okanye esasidla wolawulo. Ngokubanzi, i-additive ikhutshelwe (ngokuthobela yonke imimiselo) kakuhle zizigulane babo bonke ubudala. Ngokwesiseko ulwamkelo kusenokwenzeka ukuphuhlisa ukuphazamiseka komsebenzi kwinkqubo yokwetyisa. Ngokukodwa, kusenokuba ukuqunjelwa, isicaphucaphu, ukuqhina okanye ukurhuda, iintlungu intlungu epigastric, ubuqhophololo. Iziphumo ezingalindelekanga kufuneka kwaziwe negazi ezivela ngokuqhelekileyo kwesikhumba nerhashalala, ububomvu okanye ukukruquka kunye a ukuzwa otshisayo. Ukuba kukho naziphi na ngaphandle kwezo iziphumo elikhankanyiweyo kwicala ukuvula kufuneka ngoko nangoko ndwendwela ugqirha ukuba bayeke ukuthatha imali.
Izimo
Engamiswanga additive "+ Glucosamine Chondroitin" amacandelo hypersensitive, umsebenzi kakuhle sezintso wavakalisa kwemali. Izimo ziquka ukukhulelwa, phenylketonuria, yofuzo ukopha.
Ukusebenzisana nabanye imithi
Xa ukusebenzisa nayiphi na amayeza isigulane kufuneka azise ugqirha malunga echaza chondroprotector. Kwimeko self-iyeza kufuneka ukuba bajonge oyingcaphephe kungenzeka lokufumana izilungiso additive ukutya (ukuba kuyimfuneko) okanye nomthamo iirejimeni. Lithetha "Glucosamine + Chondroitin" kwandisa ukufunxeka tetracycline, kunciphisa kukufakwa kwemali "Chloramphenicol" kunye penicillins semisynthetic ukusuka kwinkqubo yokwetyisa. It wavumela ukusetyenziswa ngaxeshanye izongezo zokutya NPVM kunye glucocorticosteroids. Noko ke, iingcali uqaphele unciphiso kakhulu imfuneko yokuba amachiza-ukudumba ezingezo-steroid qela.
Ukuze ufumane inkcazelo engakumbi,
Ngaphambi kokuthatha isongezelelo zokutya kufuneka udibane nogqirha. Ayikhuthazwa ukuqesha yena ichiza yedwa. Ukuthintela amathuba neziphumo ezibi kufuneka ngokungqongqo wabona ugqirha emiselweyo balawule irejimeni. Kwimeko imfuneko unyango ngexesha zisanyisa isigulane kufuneka balunyukiswe lokuyeka lokuncancisa kunokwenzeka. Ngexesha lonke ikhondo unyango Kucetyiswa ukuba nokuthintela ukusetyenziswa yeswekile engamanzi. Ukwamkelwa iimveliso utywala akuvumelekanga.
Similar articles
Trending Now